Prediction of the COBRRA AF Anticoagulant Trial in Healthcare Claims Data

NCT05256797 · clinicaltrials.gov ↗

COMPLETED

Status

353980

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Rivaroxaban
DRUG: Apixaban

Sponsor

Brigham and Women's Hospital